Page 281 - 北京京煤集团总医院第十届·2022学术年会论文集
P. 281

北京京煤集团总医院                                              第十届·2022 学术年会论文集


                   5. Peng J, Zhang Q, Long X, et.Incontinentia pigmenti-associated ocular anomalies of paediatric

                   incontinentia  pigmenti  patients  in  China.  Acta  Ophthalmol.  2019  May;97(3):265-272.  doi:

                   10.1111/aos.13781. Epub 2018 Aug 3.

                   6.  任湘,张明,陆方.色素失禁症患者眼底及荧光素眼底血管造影影像特征观察[J].中华眼底病

                   杂志  2017,33(5):534-535. doi:10.3760/cma.j.issn.1005-1015.2017.05.023
                   7. Rishi P, Singh N, Rishi E. Retinopathy in incontinentia pigmenti. Indian J Ophthalmol. 2019

                   Jun;67(6):940-942. doi: 10.4103/ijo.IJO_760_18.

                   8.  Witmer  AN,  Vrensen  GF,  Van  Noorden  CJ,  et.  Vascular  endothelial  growth  factors  and

                   angiogenesis  in  eye  disease.  Prog  Retin  Eye  Res.  2003  Jan;22(1):1-29.  doi:  10.1016/s  1350-

                   9462(02)00043-5.

                   9. de Oliveira Dias JR, Rodrigues EB, Maia M, Magalhães O Jr, et. Cytokines in neovascular age-

                   related macular degeneration: fundamentals of targeted combination therapy. Br J Ophthalmol. 2011

                   Dec;95(12):1631-7. doi: 10.1136/bjo.2010.186361. Epub 2011 May 5.

                   10. Yoshinori Mitamura, Chikako Harada, Takayuki Harada. Role of cytokines and trophic factors

                   in  the  pathogenesis  of  diabetic  retinopathy.    Curr  Diabetes  Rev.  2005  Feb;1(1):73-81.  doi:

                   10.2174/1573399052952596.
                   11. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993


                   Jan;30(1):53-9. doi: 10.1136/jmg.30.1.53.
                   12. Sohn HJ, Han DH, Kim IT, et al. Changes in aqueous concentrations of various cytokines after

                   intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol. 2001;

                   152(4),686–694. doi: 10.1016/j.ajo.2011.03.033

                   13.  王亮,李曼红,张自峰等.婴幼儿色素失禁症相关眼部病变的临床特征分析[J].中华实验眼

                   科杂志  2021 年 1 月第 39 卷第 1 期  34-41. doi:10.3760/cma.j.cn115989-20200624-00451

                   14. Shiro Nakao, Sachiko Nishina, Shin Tanaka. Early laser photocoagulation for extensive retinal

                   avascularity in infants with incontinentia pigmenti. Jpn J Ophthalmol . 2020 Nov;64(6):613-620.

                   doi: 10.1007/s10384-020-00768-7. Epub 2020 Sep 8.

                   15. Yong Cheng, Xuemei Zhu, Dandan Linghu, et. Comparison of the effectiveness of conbercept

                   and  ranibizumab  treatment  for  retinopathy  of  prematurity.  Acta  Ophthalmol  .  2020  Dec;98(8):

                   e1004-e1008.    doi: 10.1111/aos.14460. Epub 2020 May 8.

                   16. Belin PJ, Lee AC, Greaves G, et. The use of bevacizumab in pediatric retinal and choroidal

                                                          - 276 -
   276   277   278   279   280   281   282   283   284   285   286